AR-2000 radio-TLC Imaging Scanner
The AR-2000 radio-TLC Imaging Scanner has become the industry ‘Gold Standard’ in the detection of radiolabeled compounds in TLC plates…and also in the purity analysis of [18F] FDG Bioscan’s AR-2000 sy...
Bioscan Inc.
Bioscan is a leading developer of advanced instrumentation for the detection, synthesis, and imaging of Radiolabeled Compounds used in four areas…
• Life Science Research
• Molecular Imaging
• Pharmaceutical Development
• Nuclear Medicine
Bioscan BioFLECT™ 400
The new Bioscan BioFLECT 400 is the first in vivo optical imaging system offering true 360° fluorescence tomography. BioFLECT uses the photon emission data acquired from 360° and a state-of-the-art 3D...
BioFLECT™ In Vivo Preclinical Imager
BioFLECT™ In Vivo Preclinical Imager - The Only True 360° Tomographic Optical Imager With the launch of the BioFLECT, Bioscan will enable researchers to realize the full potential of in vivo optical ...
Browse Products by Field
Bioscan is a leading developer of advanced instrumentation for the detection, synthesis, and imaging of Radiolabeled Compounds used in four areas…
• Life Science Research
• Molecular Imaging
• Pharmaceutical Development
• Nuclear Medicine
Bioscan is a leading provider of SPECT (Single Photon Emission Computed Tomography) and PET (Positron Emission Tomography) imaging systems for preclinical applications. Our tools enable researchers, pharmaceutical and biotech organizations to improve their drug development research using in vivo animal models.
Our patented technology improves screening of drug pipeline candidates over classic in vitro methods by providing more relevant biological data, more consistency, as well as reduced cost and complexity. The unique imaging acuity of our products also makes it possible to translate research results from mouse models of human diseases to human clinical trials – driving increased speed to market for drugs.
Bioscan is also a supplier of innovative instruments for radioisotope detection and analysis in life science, pharmaceutical and nuclear medicine research applications. As an expansion of its involvement in nuclear medicine, Bioscan now provides a variety of automated synthesis modules for the production of PET (F-18 & C-11) radiopharmaceuticals. Our analytical instruments provide solutions to both chemical purity and quality control in many applications involving radio-TLC, radio-HPLC, and isotope detection.